Scarica l'app Stockscreener
1.79
3.24%
-0.06
Precedente Chiudi:
$1.85
Aprire:
$1.91
Volume 24 ore:
187.73K
Relative Volume:
0.44
Capitalizzazione di mercato:
$259.16M
Reddito:
$18.67M
Utile/perdita netta:
$-64.78M
Rapporto P/E:
-3.1028
EPS:
-0.5769
Flusso di cassa netto:
$-37.02M
1 W Prestazione:
-5.29%
1M Prestazione:
+5.29%
6M Prestazione:
+9.15%
1 anno Prestazione:
-44.24%
Intervallo 1D:
$1.7701
$1.91
Intervallo di 1 settimana:
$1.7701
$2.035
Portata 52W:
$1.22
$3.34
Omniab Inc Stock (OABI) Company Profile
Nome
Omniab Inc
Settore
Industria
Telefono
510-250-7800
Indirizzo
5980 HORTON STREET, EMERYVILLE
Compare OABI vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OABI
Omniab Inc
|
1.79 | 259.16M | 18.67M | -64.78M | -37.02M | -0.5769 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.34 | 119.23B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
745.77 | 78.84B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
700.45 | 43.35B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
313.41 | 41.57B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.05 | 31.51B | 5.36B | 287.73M | 924.18M | 2.5229 |
Omniab Inc Stock (OABI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-11-29 | Iniziato | RBC Capital Mkts | Outperform |
| 2023-04-21 | Iniziato | The Benchmark Company | Buy |
| 2023-04-13 | Iniziato | Craig Hallum | Buy |
| 2023-02-22 | Iniziato | Cowen | Outperform |
| 2023-02-13 | Iniziato | H.C. Wainwright | Buy |
| 2022-12-20 | Iniziato | Truist | Buy |
| 2022-12-16 | Iniziato | Credit Suisse | Outperform |
| 2022-11-29 | Iniziato | SVB Leerink | Outperform |
| 2022-11-28 | Iniziato | Stifel | Buy |
Mostra tutto
Omniab Inc Borsa (OABI) Ultime notizie
OmniAb 2025 Growth: 107 Partners, 407 Programs, and New OmniUltra LaunchNews and Statistics - IndexBox
OmniAb (OABI) Q4 2025 Earnings Call Transcript - The Globe and Mail
Earnings call transcript: OmniAb beats Q4 2025 EPS forecast, stock rises - Investing.com Nigeria
Earnings Miss: Will OmniAb Inc Equity Warrant benefit from rising consumer demandEarnings Performance Report & Weekly High Conviction Trade Ideas - baoquankhu1.vn
OmniAb outlines $25M–$30M 2026 revenue guidance as partner pipeline accelerates with OmniUltra and xPloration launches - MSN
OmniAb Earnings Call Highlights Platform Growth, Cash Path - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: OmniAb (OABI) and Cresco Labs (OtherCRLBF) - The Globe and Mail
Q1 Earnings Forecast for OmniAb Issued By HC Wainwright - MarketBeat
OmniAb (NASDAQ:OABI) Upgraded to Hold at Wall Street Zen - MarketBeat
Craig-Hallum Reaffirms Their Buy Rating on OmniAb (OABI) - The Globe and Mail
Benchmark Maintains Buy on OmniAb, Inc. (OABI) March 2026 - Meyka
US Market Wrap: Is OmniAb Inc stock undervalued right now2025 Key Lessons & High Accuracy Trade Signal Alerts - baoquankhu1.vn
Revenue Check: Does OmniAb Inc stock have upside surprise potential - baoquankhu1.vn
Benchmark reiterates Buy on OmniAb stock, keeps $4 target - Investing.com
Benchmark reiterates Buy on OmniAb stock, keeps $4 target By Investing.com - Investing.com UK
OmniAb, Inc. (NASDAQ:OABI) Q4 2025 Earnings Call Transcript - Insider Monkey
HC Wainwright Estimates OmniAb's Q2 Earnings (NASDAQ:OABI) - MarketBeat
OmniAb (OABI) Receives a Buy from Stifel Nicolaus - The Globe and Mail
Weekly Earnings: Will OmniAb Inc Equity Warrant benefit from rising consumer demand2025 Growth vs Value & Weekly Breakout Watchlists - baoquankhu1.vn
OmniAb Q4 2025 slides: revenue dips but pipeline hits 407 programs - Investing.com Australia
Stifel reiterates Buy rating on OmniAb stock, cites partner growth By Investing.com - Investing.com Australia
Stifel reiterates Buy rating on OmniAb stock, cites partner growth - Investing.com India
OmniAb, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
OmniAb Q4 2025 slides: revenue dips but pipeline hits 407 programs By Investing.com - Investing.com South Africa
OmniAb Q4 2025 Earnings Call Transcript - MarketBeat
OmniAb Q4 Earnings Call Highlights - MarketBeat
OmniAb, Inc. (OABI) Reports Q4 Loss, Misses Revenue Estimates - Bitget
OmniAb Inc reports results for the quarter ended December 31Earnings Summary - TradingView
OmniAb Inc (NASDAQ:OABI) Reports Q4 and Full-Year 2025 Earnings Miss, Provides 2026 Outlook - ChartMill
OABI: 107 partners, 407 programs, new tech launches, and 2026 revenue rebound expected - TradingView
OmniAb Reports $50.3 Million Revenue for 2025 with 15% Annual Growth and Expanded Partnerships - geneonline.com
OmniAb, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
OmniAb (NASDAQ:OABI) Issues Earnings Results - MarketBeat
OmniAb Q4 revenue falls 22%, misses expectations - TradingView
OmniAb (NASDAQ: OABI) outlines 2026 guidance after lower 2025 revenue - Stock Titan
OmniAb Q4 Earnings Assessment - Benzinga
OmniAb Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights - Business Wire
A Look Ahead: OmniAb's Earnings Forecast - Benzinga
OmniAb Inc (OABI) Q4 2025 Earnings Report Preview: What To Expec - GuruFocus
Analysts Offer Insights on Healthcare Companies: Sionna Therapeutics, Inc. (SION), OmniAb (OABI) and Astrana Health (ASTH) - The Globe and Mail
OmniAb Inc expected to post a loss of 9 cents a shareEarnings Preview - TradingView
OmniAb (OABI) Projected to Post Earnings on Wednesday - Defense World
OmniAb to Participate at the Leerink Partners Global Healthcare Conference - BioSpace
OABIW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
MACD Signal: Will PFAI benefit from AI trends2025 Trade Ideas & Safe Capital Growth Stock Tips - baoquankhu1.vn
Will OmniAb Inc. Equity Warrant outperform its industry peersJuly 2025 Sentiment & Verified Entry Point Detection - mfd.ru
Is OmniAb Inc. benefiting from innovation trendsEarnings Summary Report & Consistent Return Strategy Ideas - mfd.ru
Why OmniAb Inc. Equity Warrant stock is a must watch in 2025July 2025 Gainers & Free Weekly Chart Analysis and Trade Guides - mfd.ru
OmniAb to Report Fourth Quarter 2025 Financial Results on March 4 - BioSpace
Matthew Foehr Sells 30,843 Shares of OmniAb (NASDAQ:OABI) Stock - MarketBeat
OmniAb (NASDAQ:OABI) Insider Charles Berkman Sells 9,673 Shares - MarketBeat
Omniab Inc Azioni (OABI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.48%
1.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):